FDA Approves Lilly’s Alzheimer’s Drug: A Major Step Forward In Care
The FDA’s recent approval of Lilly’s Alzheimer’s drug marks a pivotal moment in the fight against this challenging disease. Alzheimer’s, a progressive condition that affects memory and cognitive function, has long been a source of concern for families and individuals in retirement communities. This groundbreaking development not only offers hope but also opens doors to…